AQEMIA
Updated 446 days ago
- Age: 4 years
- ID: 51922341/1
1 Boulevard Pasteur Paris, France
Aqemia is a next-generation pharmatech company generating one of the world's fastest-growing drug discovery pipeline. Our mission is to scale the drug discovery process, by leveraging a unique-in-the world technology combining quantum-inspired physics and machine learning... Aqemia is an in silico drug discovery start-up, whose ambition is to discover rapidly more innovative therapeutic molecules with better chances of success... Aqemia started in 2019 as a deeptech spin-off from École normale supérieure, with a unique, multi-awarded physics theory in the rough. In only 3 years, the company has grown to an amazing team of 50+ people, built and extended repeatedly collaborations with large pharmaceutical companies, and started its own drug discovery pipeline with multiple projects ranging from hit generation to vivo assays. Aqemia's goal is to massively accelerate research projects to be able to scale to dozens of wholly or partly owned drug candidates, placed into a constellation of..
Associated domains: aqemya.com, qeemia.com